In 2026, Pharmacovigilance (PV)—the science of detecting and preventing drug side effects—has reached a critical tipping point. The sheer volume of safety data from social media, wearables, and electronic health records (EHRs) has made traditional manual review impossible, forcing a total industry shift toward AI-augmented safety.
3 Views